.
MergerLinks Header Logo

Announced

An investment consortium led a $150m Series B financing round in WuXi Diagnostics.

Financials

Edit Data
Transaction Value£106m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

diagnostics

Private Equity

Private

Friendly

Completed

Biotechnology

Minority

Venture Capital

Acquisition

China

Cross Border

Synopsis

Edit

An investment consortium led a $150m Series B financing round in WuXi Diagnostics, an integrated diagnostics platform. New investors include Thermo Fisher Scientific, Shiyu Capital, ABC International, Sunland Capital and CCBI Tech Venture, alongside existing shareholder YF Capital. "Thermo Fisher shares WuXi Diagnostics' commitment to accelerate the adoption of an integrated diagnostics approach. Our support of their effort underscores the importance of broadening the use of multi-omics data to support precision medicine and our commitment to support the expansion of high-quality care in China," Gianluca Pettiti, Thermo Fisher Scientific Senior Vice President and President of Specialty Diagnostics.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US